Prostate Cancer News and Research RSS Feed - Prostate Cancer News and Research Twitter

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Further Reading
European scientists invent new microscope for rapid detection of deadly infections

European scientists invent new microscope for rapid detection of deadly infections

A group of European scientists have invented a microscope that will allow the fastest ever detection of life-threatening infections caused by bacteria, such as E. coli or Staphylococcus, and conditions such as Meningitis, saving millions of lives every year. [More]
NYU Lutheran offers many treatment options for kidney stone sufferers

NYU Lutheran offers many treatment options for kidney stone sufferers

Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones. [More]
New MRI method detects low zinc levels to help identify healthy prostate tissue from cancer

New MRI method detects low zinc levels to help identify healthy prostate tissue from cancer

A novel MRI method that detects low levels of zinc ion can help distinguish healthy prostate tissue from cancer, UT Southwestern Medical Center radiologists have determined. [More]
Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Food provides us with a variety of substances we need to maintain life. These substances are essential nutrients and are classified as macronutrients (water, protein, fats, and carbohydrates) and micronutrients (vitamins and minerals). [More]
Study highlights racial/ethnic disparities in genomic sequencing

Study highlights racial/ethnic disparities in genomic sequencing

As scientists learn more about which genetic mutations are driving different types of cancer, they're targeting treatments to small numbers of patients with the potential for big payoffs in improved outcomes. [More]
New study shows female urologists perform more surgeries on women than male counterparts

New study shows female urologists perform more surgeries on women than male counterparts

Although female certified urologists are still a minority within the specialty, they perform many more procedures on women than their male colleagues, who perform more procedures on men than their female colleagues. [More]
IRB Barcelona scientists rediscover utility of disordered proteins as therapeutic targets

IRB Barcelona scientists rediscover utility of disordered proteins as therapeutic targets

Prostate cancer, Alzheimer's, Parkinson's...these three diseases are associated with proteins that share a common feature, namely disordered regions that have no apparent rigid three-dimensional structure. [More]
Novel computational analysis of prostate cancer suggests potential targets for therapy

Novel computational analysis of prostate cancer suggests potential targets for therapy

Cancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment. [More]
SBP board member donates $1M for researchers to study pancreatic and prostate cancer

SBP board member donates $1M for researchers to study pancreatic and prostate cancer

Sanford Burnham Prebys Medical Discovery Institute (SBP) has received a $1M donation from The Epstein Family Foundation for scientists to study pancreatic and prostate cancer. [More]
Economic crisis linked to cancer mortality increase? An interview with Dr Mahiben Maruthappu

Economic crisis linked to cancer mortality increase? An interview with Dr Mahiben Maruthappu

We found that the recent global economic crisis may have been associated with 260,000 additional cancer deaths in the OECD, between 2008 and 2010 alone. [More]
Wistar scientists discover novel mechanism that helps tumors adapt to hypoxia

Wistar scientists discover novel mechanism that helps tumors adapt to hypoxia

One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions. [More]
Novel compound holds potential for next-generation prostate cancer treatment

Novel compound holds potential for next-generation prostate cancer treatment

In the search for new ways to attack recurrent prostate cancer, researchers at Duke Health report that a novel compound appears to have a unique way of blocking testosterone from fueling the tumors in mice. [More]
Combination of examination and radical local therapy can improve survival of men with prostate cancer

Combination of examination and radical local therapy can improve survival of men with prostate cancer

Men with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality risk of men who are treated at hospitals with the lowest proportion. [More]
Immunotherapy innovations in oncology: an interview with Robert LaCaze

Immunotherapy innovations in oncology: an interview with Robert LaCaze

The body’s immune system is an excellent weapon against many diseases. For more than 100 years, immunology and immunotherapy have played an ever-increasing role in the understanding and treatment of cancer. [More]
African-American men treated with ADT for prostate cancer suffer from high mortality rates

African-American men treated with ADT for prostate cancer suffer from high mortality rates

In a retrospective study analyzing patients' medical records, researchers at Brigham and Women's Hospital found that patients' race significantly affected their longevity by increasing the likelihood of death after receiving androgen deprivation therapy (ADT). [More]
Scientists identify new way to impair tumour growth in lung cancer

Scientists identify new way to impair tumour growth in lung cancer

Researchers from the Cancer Science Institute of Singapore at the National University of Singapore, in collaboration with Harvard Stem Cell Institute, have discovered a new way in which the development of lung cancer can be stopped. [More]
Scientists engineer therapeutic system with two arms to get better hold on cancer target

Scientists engineer therapeutic system with two arms to get better hold on cancer target

Scientists have engineered a sort of biological barbell that can get inside cancer cells and do damage to two proteins that work independently and together to enable cancer's survival and spread. [More]

Erectile dysfunction drugs do not play role in preventing prostate cancer, study shows

While some previous studies have indicated that taking erectile dysfunction (ED) drugs may reduce the likelihood of developing prostate cancer, new research published in The Journal of Urology found that these drugs do not play a role in preventing prostate cancer. [More]
Cell-free DNA test could help identify liver transplant patients with acute rejection

Cell-free DNA test could help identify liver transplant patients with acute rejection

Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests. [More]
Robotic and open surgeries for prostate cancer achieve similar quality of life outcomes at 3 months

Robotic and open surgeries for prostate cancer achieve similar quality of life outcomes at 3 months

The first randomised controlled trial to directly compare robotic surgery with open surgery for patients with localised prostate cancer finds that robotic and open surgery achieve similar results in terms of key quality of life indicators at 3 months. [More]
Advertisement
Advertisement